Literature DB >> 18632464

Management of hot flashes in men with prostate cancer being treated with androgen deprivation therapy.

Todd J Alekshun1, Stephen G Patterson.   

Abstract

The use of androgen deprivation therapy (ADT) to treat prostate cancer has favorably impacted outcomes for men with prostate cancer. Androgen deprivation therapy is effective in reducing painful bony metastases and soft tissue visceral disease in advanced-stage prostate cancer. The use of ADT has expanded beyond the metastatic setting and can also be used as adjuvant therapy for patients with locally advanced prostate cancer who received surgery or localized radiation therapy. Luteinizing hormone-releasing hormone agonists are the most common medical therapy used to deprive men of androgen production. Despite the beneficial effects that ADT has on prostate cancer, ADT causes side effects that can impair quality of life. This article will review the impact and treatment of hot flashes in men treated for prostate cancer.

Entities:  

Year:  2006        PMID: 18632464     DOI: 10.3816/SCT.2006.n.029

Source DB:  PubMed          Journal:  Support Cancer Ther        ISSN: 1543-2912


  2 in total

1.  Venlafaxine for the treatment of hormonal therapy-induced hot flashes in a male patient.

Authors:  Harmit Singh; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.

Authors:  Brian Hutton; Fatemeh Yazdi; Louise Bordeleau; Scott Morgan; Chris Cameron; Salmaan Kanji; Dean Fergusson; Andrea Tricco; Sharon Straus; Becky Skidmore; Mona Hersi; Misty Pratt; Sasha Mazzarello; Melissa Brouwers; David Moher; Mark Clemons
Journal:  Syst Rev       Date:  2015-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.